Home Medical 3D Printing Company AREVO Secures $ 7 Million in Series A Funding

3D Printing Company AREVO Secures $ 7 Million in Series A Funding

Silicon Valley-based startup AREVO has secured a $ 7 million Serie A funding round led by Khosla Ventures. 

AREVO has introduced their multi-axis robotic additive manufacturing platform back in November last year and is also working on composite materials featuring five times the strength of titanium as well a a cloud-based software solution optimising fibre placement in 3D designs to achieve the highest strength-to-weight ratio.

The multi-axis robotic platform consists of a standard commercially available robot, composite deposition hardware and a software suite. The platform allows for the production of 3D printed quality parts with true 3D surfaces in variable orientations. According to AREVO, the parts have strength and aesthetics superior to those produced by conventional AM systems.

“We are pleased to continue our momentum with this important investment round led by Khosla Ventures,” said Hemant Bheda, CEO and Founder of AREVO. “Our 3D printing technology and software suites will lead to higher quality parts in the aerospace, medical, and automotive industries. This funding will enable us to meet our near-term product development objectives, which will be announced later this year.”

Vijit Sabnis from Khosla Ventures, who now join the AREVO Board of Directors, stated: “We at Khosla Ventures have been impressed by Hemant’s team and the vision put forth by AREVO, which we feel offers disruptive technology to 3D print production parts with unique characteristics, achieving a performance that cannot be matched using any conventional method or other additive manufacturing technique.


Subscribe to our Newsletter

3DPResso is a weekly newsletter that links to the most exciting global stories from the 3D printing and additive manufacturing industry.

Privacy Policy*
 

You can find the privacy policy for the newsletter here. You can unsubscribe from the newsletter at any time. For further questions, you can contact us here.